Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID
International Journal of Molecular Sciences · 25.06.2025 · 26 (13) · 6082
DOI: 10.3390/ijms26136082 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.06.2025. Verfasst von Gong-Hua Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Evolution and Animal Models, Key Laboratory of Healthy Aging Research of Yunnan Province, Kunming Key Laboratory of H…. Hauptthemen laut MEDLINE: COVID-19, Fatigue Syndrome, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Medicine Foundation, Yunnan Ten Thousand Talents Plan Young & Elite Talents Project, Yunnan Fundamental Research Projects.
Abstract (Originalsprache)
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID are complex multisystem conditions that pose significant challenges in healthcare. Accumulated research evidence suggests that ME/CFS and Long COVID exhibit overlapping metabolic symptoms, indicating potential shared metabolic dysfunctions. This study aims to systematically explore shared metabolic disturbances in the muscle tissue of patients. Utilizing genome-wide metabolic modeling, we identified key metabolic irregularities in the muscle of patients with ME/CFS, notably the downregulation of the alanine and aspartate metabolism pathway and the arginine and proline metabolism pathway. Further, in silico knockout analyses suggested that supplementation with aspartate (ASP) or asparagine (ASN) could potentially ameliorate these metabolic deficiencies. In addition, assessments of metabolomic levels in Long COVID patients also showed the significant downregulation of ASP during post-exertional malaise (PEM) in both muscle and blood. Consequently, we propose that a combination of l-ornithine and l-aspartate (LOLA) is a potential candidate to alleviate metabolic symptoms in ME/CFS and Long COVID for future clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Evolution and Animal Models, Key Laboratory of Healthy Aging Research of Yunnan Province, Kunming Key Laboratory of Healthy Aging Study, KIZ/CUHK Joint Laboratory of Bioresources and Mole…
- Computational Research Center for Complex Chronic Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Independent Researcher, 185 37 Pireas, Greece.
- CAS Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming 650223, China.
ORCID-Profile: Gong-Hua Li, Efthymios Kalafatis, Qing-Peng Kong, Wenzhong Xiao
Förderung
- Open Medicine Foundation
- Yunnan Ten Thousand Talents Plan Young & Elite Talents Project
- Yunnan Fundamental Research Projects
Zitieren
APA
Li, G. H., Han, F. F., Kalafatis, E., Kong, Q. P., & Xiao, W. (2025). Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID. International Journal of Molecular Sciences, 26(13), 6082. https://doi.org/10.3390/ijms26136082
Vancouver
Li GH, Han FF, Kalafatis E, Kong QP, Xiao W. Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID. International Journal of Molecular Sciences. 2025;26(13):6082. doi:10.3390/ijms26136082
BibTeX
@article{Li2025,
author = {Li, Gong-Hua and Han, Fei-Fei and Kalafatis, Efthymios and Kong, Qing-Peng and Xiao, Wenzhong},
title = {Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6082},
doi = {10.3390/ijms26136082}
}
EUVIMED